Danai Dima

2.4k citations
105 papers · 1.4k · 2 hit papers · h-index 20

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
  • Oncology top 5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Viral-associated cancers and disorders

Papers in

    • Multiple Myeloma Research and Treatments 52
    • Acute Myeloid Leukemia Research 8
    • Hematopoietic Stem Cell Transplantation 4
    • CAR-T cell therapy research 43
    • Viral-associated cancers and disorders 2

Danai Dima

92 papers receiving 1.4k citations

Danai Dima's Hit Papers

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma 2024 · 93 citations
930+1+2Years since publication50100150200

Peers

Danai Dima
Comparison fields: 5 of 60
  • Hematology 818
  • Oncology 692
  • Internal Medicine 12
  • Toxicology 13
  • Pathology and Forensic Medicine 41
Replace Shebli Atrash with:
Shebli Atrash United States
Roberto Mina Italy
Benjamin Avi Derman United States
Sonia Ronconi Italy
Omar Nadeem United States
Susana Vives Spain
Robin L. Carson United States
Nour M. Moukalled Lebanon
Rebecca E. Garris United States
Zandra Karina Klippel United States
Danai Dima relative to Shebli Atrash United States Shebli Atrash's profile →
Citations per field
00.5×2×2.6×
Shebli Atrash · 1×
Citations per year

Countries citing papers authored by Danai Dima

Since Specialization
Citations

This map shows the geographic impact of Danai Dima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danai Dima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danai Dima more than expected).

Fields of papers citing papers by Danai Dima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danai Dima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danai Dima. The network helps show where Danai Dima may publish in the future.

Co-authors

The 25 scholars most cited alongside Danai Dima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danai Dima Line = papers co-authored together Danai Dima links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium
Hit paper breakdown →
2023234
2 202393
3
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma
Hit paper breakdown →
202493
4 202368
5 202459
6 202351
7 202246
8 202346
9 202340
10 202440
11 202038
12 202338
13 202334
14 202434
15 202531
16 202430
17 202329
18 202425
19 202323
20 202320

About Danai Dima

Danai Dima is a scholar working on Hematology, Oncology, Immunology, Pathology and Forensic Medicine and Emergency Medicine, having authored 105 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (52 papers), CAR-T cell therapy research (43 papers), Acute Myeloid Leukemia Research (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Hematopoietic Stem Cell Transplantation (4 papers), Complement system in diseases (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hematology (818 citations), Oncology (692 citations), Internal Medicine (12 citations), Toxicology (13 citations) and Pathology and Forensic Medicine (41 citations). Danai Dima has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Fauzia Ullah, Jack Khouri, Faiz Anwer, Shahzad Raza, Joshua Dower, Jason Neil Valent, Raymond L. Comenzo, Al-Ola A. Abdallah, Hamza Hashmi and Cindy Varga. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Blood Cancer Journal, Cancers and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact